Richard King, Founder of Spruce Biosciences

Richard King is the founder of Spruce Biosciences. Spruce Biosciences has raised $88M in total funding. Latest round: Series B.

About Richard King

Richard King is the CEO of Spruce Biosciences, a clinical-stage biotechnology company developing and commercializing therapies for rare endocrine disorders. Spruce’s lead program is tildacerfont, an investigational oral drug for congenital adrenal hyperplasia (CAH).

Richard King at a glance

More founders in South San Francisco, United States (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library